Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.83 Million ≈ $16.07 Million USD) by net assets (CN¥2.41 Billion ≈ $352.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Shenqi Pharmaceutical Investmen (600613) liquidity interval to measure how many days the company can operate on defensive assets alone.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Maha Energy AB (publ) ST:MAHA-A	-0.038x
Baader Bank Aktiengesellschaft F:BWB	N/A
Vetropack Holding SA SW:VETN	0.157x
ASYMCHEM LAB.(TIAN.)H YC1 F:7K90	N/A
Masterwork Machinery SHE:300195	0.014x
i3system Inc KQ:214430	0.073x
Fiera Capital Corporation TO:FSZ	0.138x
Xiamen Goldenhome Co Ltd SHG:603180	-0.071x

Annual Cash Flow Conversion Efficiency for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Shenqi Pharmaceutical Investmen.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.40 Billion ≈ $350.83 Million	CN¥124.47 Million ≈ $18.21 Million	0.052x	-39.36%
2024-12-31	CN¥2.43 Billion ≈ $355.12 Million	CN¥207.79 Million ≈ $30.41 Million	0.086x	-5.06%
2023-12-31	CN¥2.39 Billion ≈ $349.81 Million	CN¥215.59 Million ≈ $31.55 Million	0.090x	-32.96%
2022-12-31	CN¥2.37 Billion ≈ $347.27 Million	CN¥319.23 Million ≈ $46.71 Million	0.135x	+74.66%
2021-12-31	CN¥2.39 Billion ≈ $350.10 Million	CN¥184.26 Million ≈ $26.96 Million	0.077x	+80.90%
2020-12-31	CN¥2.33 Billion ≈ $340.61 Million	CN¥99.10 Million ≈ $14.50 Million	0.043x	-11.67%
2019-12-31	CN¥2.66 Billion ≈ $389.47 Million	CN¥128.28 Million ≈ $18.77 Million	0.048x	-15.67%
2018-12-31	CN¥2.60 Billion ≈ $380.28 Million	CN¥148.53 Million ≈ $21.73 Million	0.057x	+115.90%
2017-12-31	CN¥2.53 Billion ≈ $370.30 Million	CN¥66.99 Million ≈ $9.80 Million	0.026x	+11200.00%
2016-12-31	CN¥2.43 Billion ≈ $356.31 Million	CN¥570.41K ≈ $83.47K	0.000x	-98.22%
2015-12-31	CN¥2.29 Billion ≈ $334.49 Million	CN¥30.12 Million ≈ $4.41 Million	0.013x	+405.40%
2014-12-31	CN¥2.00 Billion ≈ $292.37 Million	CN¥-8.62 Million ≈ $-1.26 Million	-0.004x	-110.46%
2013-12-31	CN¥1.81 Billion ≈ $265.15 Million	CN¥74.75 Million ≈ $10.94 Million	0.041x	+183.60%
2012-12-31	CN¥226.61 Million ≈ $33.16 Million	CN¥-11.18 Million ≈ $-1.64 Million	-0.049x	-213.50%
2011-12-31	CN¥211.50 Million ≈ $30.95 Million	CN¥-3.33 Million ≈ $-487.11K	-0.016x	-109.17%
2010-12-31	CN¥192.37 Million ≈ $28.15 Million	CN¥33.04 Million ≈ $4.83 Million	0.172x	+309.61%
2009-12-31	CN¥183.43 Million ≈ $26.84 Million	CN¥7.69 Million ≈ $1.13 Million	0.042x	-65.35%
2008-12-31	CN¥208.82 Million ≈ $30.56 Million	CN¥25.26 Million ≈ $3.70 Million	0.121x	+54.40%
2007-12-31	CN¥204.29 Million ≈ $29.89 Million	CN¥16.01 Million ≈ $2.34 Million	0.078x	+344.25%
2006-12-31	CN¥188.49 Million ≈ $27.58 Million	CN¥-6.05 Million ≈ $-884.87K	-0.032x	-118.13%
2005-12-31	CN¥184.92 Million ≈ $27.06 Million	CN¥32.72 Million ≈ $4.79 Million	0.177x	+528.48%
2004-12-31	CN¥176.21 Million ≈ $25.79 Million	CN¥4.96 Million ≈ $725.94K	0.028x	-6.34%
2003-12-31	CN¥150.23 Million ≈ $21.98 Million	CN¥4.52 Million ≈ $660.84K	0.030x	-72.58%
2002-12-31	CN¥146.14 Million ≈ $21.38 Million	CN¥16.02 Million ≈ $2.34 Million	0.110x	+234.59%
2001-12-31	CN¥251.84 Million ≈ $36.85 Million	CN¥-20.51 Million ≈ $-3.00 Million	-0.081x	-209.56%
2000-12-31	CN¥361.16 Million ≈ $52.85 Million	CN¥26.85 Million ≈ $3.93 Million	0.074x	+864.07%
1999-12-31	CN¥336.74 Million ≈ $49.28 Million	CN¥-3.28 Million ≈ $-479.48K	-0.010x	-104.86%
1998-12-31	CN¥363.26 Million ≈ $53.16 Million	CN¥72.67 Million ≈ $10.63 Million	0.200x	--

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General

Market Cap

$331.76 Million

CN¥2.27 Billion CNY

Market Cap Rank

#14437 Global

#4315 in China

Share Price

CN¥4.73

Change (1 day)

-0.21%

52-Week Range

CN¥4.73 - CN¥7.19

All Time High

CN¥24.35